You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

germline BRCA2 and/or PALB2 mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

Active, not recruiting
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 10, 2021

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Searching for Novel Germline Mutations in Lobular Breast Cancer

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Illumina panel
  • Milan, Italy
    European Institute of Oncology
Sep 12, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

      Recruiting
      • Ovarian Cancer
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Jul 13, 2022

        Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • +7 more
        • (no location specified)
        Aug 1, 2022

        HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

        Recruiting
        • HER2-negative Breast Cancer
        • +2 more
        • Barcelona, Spain
        • +4 more
        Apr 14, 2022

        Molecular Profiling in Prostate Cancer

        Recruiting
        • Prostate Cancer Metastatic
        • +4 more
        • Tumor molecular profiling
        • Athens, Greece
          Hellenic Cooperative Oncology Group
        Mar 15, 2022

        Breast & Ovarian Cancer Risk Detection

        Recruiting
        • Adnexal Mass
        • +3 more
        • OVA360
        • Austin, Texas
          Silvana Franco
        Jul 20, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

        Active, not recruiting
        Has Results
        • BRCA1 Gene Mutation
        • +5 more
        • Durvalumab
        • +3 more
        • Buffalo, New York
        • +1 more
        Jan 20, 2023

        BRCA1/2 Flu Vaccine

        Active, not recruiting
        • BRCA1 Mutation
        • BRCA2 Mutation
        • Seasonal influenza vaccine
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Aug 16, 2022

        Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

        Not yet recruiting
        • Prostate Adenocarcinoma
        • +2 more
        • Biospecimen Collection
        • +6 more
        • (no location specified)
        Mar 28, 2023

        GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

        Not yet recruiting
        • GATA2 Gene Mutation
        • Biological samples (blood and bone marrow samples).
        • Angers, France
        • +16 more
        Jul 31, 2023

        Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

        Active, not recruiting
        • Advanced Breast Cancer
        • +2 more
        • Talazoparib Tosylate
        • Stanford, California
          Stanford University Hospitals and Clinics
        Nov 16, 2022

        BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

        Not yet recruiting
        • BRCA Mutation
        • +3 more
        • Tamoxifen 10 Mg Tablet
        • +2 more
        • Genoa, Italy
        • +3 more
        Sep 11, 2023

        Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

        Recruiting
        • Advanced Breast Carcinoma
        • +14 more
        • Houston, Texas
          M D Anderson Cancer Center
        Mar 31, 2022

        Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

        Not yet recruiting
        • Prostate Cancer
        • +4 more
        • (no location specified)
        Aug 10, 2022

        Breast Cancer After Ovarian Cancer During and/or After Therapy:

        Recruiting
        • BRCA-Associated Breast Carcinoma
        • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 9, 2023

        Breast Cancer Trial in France (Main study:, Sub-study:)

        Recruiting
        • Breast Cancer
        • Main study:
        • Sub-study:
        • Bordeaux, France
        • +20 more
        Jan 2, 2023